BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35763382)

  • 1.
    Chen S; Zhang W; Yuan D; Yu W; Ye X; Ling C
    Genet Test Mol Biomarkers; 2022 Jun; 26(6):340-347. PubMed ID: 35763382
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathologic Features and the Prognostic Implications of Long Noncoding RNA
    Xiong F; Yin H; Zhang H; Zhu C; Zhang B; Chen S; Ling C; Chen X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):47-53. PubMed ID: 31880484
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Long Non-Coding RNA PRAL as a Potential Biomarker for Diagnosis in Non-Small-Cell Lung Cancer Patients is Associated with the Inhibition of Cell Proliferation and Metastasis.
    Wang H; Wang J; Liang CF; Zhou T
    Clin Lab; 2018 Sep; 64(9):1341-1348. PubMed ID: 30274002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non‑coding RNA FEZF1‑AS1 facilitates non‑small cell lung cancer progression via the ITGA11/miR‑516b‑5p axis.
    Song H; Li H; Ding X; Li M; Shen H; Li Y; Zhang X; Xing L
    Int J Oncol; 2020 Dec; 57(6):1333-1347. PubMed ID: 33174014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00116 enhances cervical cancer tumorigenesis through miR-106a/c-Jun pathway.
    Lai Y; Zhou B; Tan Q; Xu J; Wan T; Zhang L
    J Cell Biochem; 2020 Mar; 121(3):2247-2257. PubMed ID: 31693227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer.
    Xu T; Liu X; Han L; Shen H; Liu L; Shu Y
    Clin Transl Oncol; 2014 May; 16(5):469-75. PubMed ID: 24019037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
    Liu X; Huang G; Zhang J; Zhang L; Liang Z
    PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
    Huang S; Qing C; Huang Z; Zhu Y
    Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA activated by transforming growth factor-β promotes cancer development and is a prognostic marker in cervical cancer.
    Cao W; Peng T; Zhou Y
    J Cancer Res Ther; 2017; 13(5):801-806. PubMed ID: 29237907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
    Lin L; Gu ZT; Chen WH; Cao KJ
    Diagn Pathol; 2015 Mar; 10():14. PubMed ID: 25889788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
    Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
    Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
    J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased long noncoding RNA LINP1 expression and its prognostic significance in human breast cancer.
    Liu XM; Yang B; Han J
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8749-8754. PubMed ID: 30575915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
    Jing H; Qu X; Liu L; Xia H
    Med Sci Monit; 2018 Jun; 24():4317-4323. PubMed ID: 29935018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of long noncoding RNA Sox2ot is associated with the aggressive progression and poor outcome of gastric cancer.
    Zou JH; Li CY; Bao J; Zheng GQ
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4482-4486. PubMed ID: 27874951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The up-regulation of long non-coding RNA AFAP1-AS1 is associated with the poor prognosis of NSCLC patients.
    Deng J; Liang Y; Liu C; He S; Wang S
    Biomed Pharmacother; 2015 Oct; 75():8-11. PubMed ID: 26463625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.